ORLANDO, Fla., Aug. 18, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-BB: TNIB) ("we" or the "Company") a biotechnology company pioneering the manufacturing and marketing of innovative therapies for autoimmune diseases in emerging nations, announced today that the Company is providing a second notice of TNI BioTech's annual meeting of September 4, 2014.
In making the announcement, Noreen Griffin, founder and CEO of TNI BioTech Inc. said, "Thank you in advance for your participation in the Annual Meeting. On behalf of our employees and Board of Directors, I would like to express our appreciation for your continued interest in TNIB. In addition the Company has received numerous calls from shareholders concerning voting for the annual meeting to be held September 4, 2014.
"If you have received your packet, and will not be able to attend the meeting in person, please mail in your proxy and ballot as soon as possible. We have received a very limited amount of proxy and ballots via mail to date.
"We have elected to provide access to our proxy materials over the Internet under the Securities and Exchange Commission's 'notice and access' rules. On or about July 22, 2014, we mailed certain of our stockholders a Notice of Internet Availability of Proxy Materials, or Internet Notice, containing instructions on how to access our 2014 proxy statement and annual report and instructions on how to vote online, by telephone or request a paper copy of our proxy materials. Our proxy statement and annual report are available on our website at www.tnibiotech.com/investor-relations/proxy-statements.
"Only stockholders of record at the close of business on July 15, 2014, are entitled to notice of and to vote at the Annual Meeting and at any adjournment or postponement thereof.
"Whether or not you ex
|SOURCE TNI BioTech, Inc.|
Copyright©2014 PR Newswire.
All rights reserved